Pinnacle Wealth Planning Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
9,951
+155
| +2% | +$5.95K | 0.05% | 245 |
|
|
2025
Q1 | $379K | Buy |
9,796
+1,167
| +14% | +$45.2K | 0.06% | 215 |
|
|
2024
Q4 | $292K | Sell |
8,629
-2,050
| -19% | -$69.3K | 0.04% | 256 |
|
|
2024
Q3 | $437K | Buy |
10,679
+784
| +8% | +$32K | 0.06% | 213 |
|
|
2024
Q2 | $381K | Sell |
9,895
-181
| -2% | -$6.97K | 0.05% | 226 |
|
|
2024
Q1 | $432K | Sell |
10,076
-721
| -7% | -$30.9K | 0.06% | 215 |
|
|
2023
Q4 | $400K | Buy |
10,797
+2,652
| +33% | +$98.3K | 0.06% | 209 |
|
|
2023
Q3 | $295K | Buy |
8,145
+2,218
| +37% | +$80.4K | 0.05% | 256 |
|
|
2023
Q2 | $211K | Buy |
+5,927
| New | +$211K | 0.03% | 368 |
|
|
2022
Q3 | – | Sell |
-7,576
| Closed | -$412K | – | 419 |
|
|
2022
Q2 | $412K | Buy |
7,576
+867
| +13% | +$47.1K | 0.07% | 185 |
|
|
2022
Q1 | $365K | Buy |
6,709
+860
| +15% | +$46.8K | 0.07% | 229 |
|
|
2021
Q4 | $322K | Buy |
5,849
+1,379
| +31% | +$75.9K | 0.06% | 248 |
|
|
2021
Q3 | $213K | Buy |
+4,470
| New | +$213K | 0.05% | 317 |
|
|
2021
Q1 | – | Sell |
-1,946
| Closed | -$89K | – | 1003 |
|
|
2020
Q4 | $89K | Buy |
+1,946
| New | +$89K | 0.02% | 521 |
|
|
2018
Q4 | – | Sell |
-6,160
| Closed | -$309K | – | 166 |
|
|
2018
Q3 | $309K | Sell |
6,160
-10
| -0.2% | -$502 | 0.28% | 119 |
|
|
2018
Q2 | $312K | Sell |
6,170
-2,282
| -27% | -$115K | 0.3% | 105 |
|
|
2018
Q1 | $413K | Buy |
8,452
+6,738
| +393% | +$329K | 0.42% | 80 |
|
|
2017
Q4 | $76K | Buy |
+1,714
| New | +$76K | 0.15% | 106 |
|